Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Statistics
  • Help & Advice
University of Warwick

The Library

  • Login

Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor

Tools
- Tools
+ Tools

Talbert-Slagle, Kristina, Marlatt, Sara, Barrera, Francisco N., Khurana, Ekta, Oates, Joanne, Gerstein, Mark, Engelman, Donald M., Dixon, Ann M. and DiMaio, Daniel. (2009) Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor. Journal of Virology, Vol.83 (No.19). pp. 9773-9785. ISSN 0022-538X

Full text not available from this repository.
Official URL: http://dx.doi.org/10.1128/JVI.00946-09

Abstract

The bovine papillomavirus E5 protein (BPV E5) is a 44-amino-acid homodimeric transmembrane protein that binds directly to the transmembrane domain of the platelet-derived growth factor (PDGF) beta receptor and induces ligand-independent receptor activation. Three specific features of BPV E5 are considered important for its ability to activate the PDGF beta receptor and transform mouse fibroblasts: a pair of C-terminal cysteines, a transmembrane glutamine, and a juxtamembrane aspartic acid. By using a new genetic technique to screen libraries expressing artificial transmembrane proteins for activators of the PDGF beta receptor, we isolated much smaller proteins, from 32 to 36 residues, that lack all three of these features yet still dimerize noncovalently, specifically activate the PDGF beta receptor via its transmembrane domain, and transform cells efficiently. The primary amino acid sequence of BPV E5 is virtually unrecognizable in some of these proteins, which share as few as seven consecutive amino acids with the viral protein. Thus, small artificial proteins that bear little resemblance to a viral oncoprotein can nevertheless productively interact with the same cellular target. We speculate that similar cellular proteins may exist but have been overlooked due to their small size and hydrophobicity.

Item Type: Journal Article
Subjects: Q Science > QP Physiology
Q Science > QR Microbiology > QR355 Virology
Divisions: Faculty of Science > Chemistry
Library of Congress Subject Headings (LCSH): Protein binding, Papillomaviruses, Cell transformation, Proteins -- Research, Ligand binding (Biochemistry)
Journal or Publication Title: Journal of Virology
Publisher: American Society for Microbiology
ISSN: 0022-538X
Date: October 2009
Volume: Vol.83
Number: No.19
Number of Pages: 13
Page Range: pp. 9773-9785
Identification Number: 10.1128/JVI.00946-09
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access
Funder: Fundacion Alfonso Martin Escudero, Cancer Research UK (CRUK), National Institutes of Health (U.S.)
Grant number: C21449/A6926 (CR-UK), CA37157 (NIH)
URI: http://wrap.warwick.ac.uk/id/eprint/17342

Data sourced from Thomson Reuters' Web of Knowledge

Request changes to a record

Actions (login required)

View Item View Item
twitter

Email us: publications@warwick.ac.uk
Contact Details
About Us